Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics Limited has released its annual report for the year ended June 30, 2024, providing a comprehensive review of the company’s operations, financial state, and future outlook. The report includes details on director activities, principal activities, environmental impacts, and audited financial statements. It aims to offer shareholders insights into the company’s performance and strategic direction.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.